Editorial 1: Clinical Nanomedicine, a New Nano Domain

Heinrich Rohrer,

doi:10.1515/EJNM.2010.3.1.4

Home Editorial 1: Clinical Nanomedicine, a New Nano Domain

Article

Licensed

Unlicensed Requires Authentication

Editorial 1: Clinical Nanomedicine, a New Nano Domain

Heinrich Rohrer,

Published/Copyright: May 1, 2010

Published by

Become an author with De Gruyter Brill

Author Information

From the journal European Journal of Nanomedicine Volume 3 Issue 1

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

Rohrer,, Heinrich. "Editorial 1: Clinical Nanomedicine, a New Nano Domain" European Journal of Nanomedicine, vol. 3, no. 1, 2010, pp. 4-4. https://doi.org/10.1515/EJNM.2010.3.1.4

Rohrer,, H. (2010). Editorial 1: Clinical Nanomedicine, a New Nano Domain. European Journal of Nanomedicine, 3(1), 4-4. https://doi.org/10.1515/EJNM.2010.3.1.4

Rohrer,, H. (2010) Editorial 1: Clinical Nanomedicine, a New Nano Domain. European Journal of Nanomedicine, Vol. 3 (Issue 1), pp. 4-4. https://doi.org/10.1515/EJNM.2010.3.1.4

Rohrer,, Heinrich. "Editorial 1: Clinical Nanomedicine, a New Nano Domain" European Journal of Nanomedicine 3, no. 1 (2010): 4-4. https://doi.org/10.1515/EJNM.2010.3.1.4

Rohrer, H. Editorial 1: Clinical Nanomedicine, a New Nano Domain. European Journal of Nanomedicine. 2010;3(1): 4-4. https://doi.org/10.1515/EJNM.2010.3.1.4

Copy

Copied to clipboard

BibTeX EndNote RIS

Published Online: 2010-05

Published in Print: 2010-05

You are currently not able to access this content.

Articles in the same Issue

Editorial 1: Clinical Nanomedicine, a New Nano Domain
Editorial 2: Editorial from the CEO
Editorial 3: Nanomedicine – shaping the future of medicine in a context of academia, industry and politics
Clinical Nanomedicine: Nanomedical approaches in Alzheimer’s disease
Nanophysiology: The Janus Face of Immune Stimulation by Nanomedicines: Examples for the Good and the Bad
Therapeutic Nanomedicine: Cross linked micelles with transiently linked drugs – a versatile drug delivery system
Preventive Nanomedicine: Nanomedicine for dendritic cell-targeted immunotherapy
Nanomethods: Scanning X-ray scattering: Evaluating the nanostructure of human tissues
Nanopharmaceuticals: Nanopharmaceuticals
The Landscape of Nanomedicine: Nanomedicine and Nanotoxicology at PHARMA–Copenhagen University

Search journal Search the content of this journal

https://doi.org/10.1515/EJNM.2010.3.1.4

Articles in the same Issue

Editorial 1: Clinical Nanomedicine, a New Nano Domain
Editorial 2: Editorial from the CEO
Editorial 3: Nanomedicine – shaping the future of medicine in a context of academia, industry and politics
Clinical Nanomedicine: Nanomedical approaches in Alzheimer’s disease
Nanophysiology: The Janus Face of Immune Stimulation by Nanomedicines: Examples for the Good and the Bad
Therapeutic Nanomedicine: Cross linked micelles with transiently linked drugs – a versatile drug delivery system
Preventive Nanomedicine: Nanomedicine for dendritic cell-targeted immunotherapy
Nanomethods: Scanning X-ray scattering: Evaluating the nanostructure of human tissues
Nanopharmaceuticals: Nanopharmaceuticals
The Landscape of Nanomedicine: Nanomedicine and Nanotoxicology at PHARMA–Copenhagen University